The U.S. Food and Drug Administration has proposed removing oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it ...
Full results have not yet been published, but according to Amgen findings showed treatment with tezepelumab statistically significantly and clinically meaningfully reduced the size of nasal polyps and ...